P66-6 Efficacy of everolimus in HR+ HER2- metastatic breast cancer patients after progression on CDK4/6 inhibitorsKenichi Watanabe,Sayuri Kuwahara,Hanae Tachikawa,Hideki Maeda,Mitsugu Yamamoto,Nobumoto Tomioka,Masato TakahashiAnnals of Oncology(2022)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要